Stereotaxis, Inc. (STXS) Stock

Stereotaxis, Inc. (STXS) is a Healthcare stock trading at $1.88 (as of 2026-06-18), with a market capitalization of $193.52M and a trailing P/E of -8.3. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Stereotaxis, Inc. develops and sells robotic magnetic navigation systems, related imaging hardware, and procedure information solutions used in interventional labs. Its offerings include RMN systems for image-guided catheter and guidewire navigation, real-time networking software to manage and share procedures, and associated disposables and accessories.

Valuation — source: SEC EDGAR (first-party)
Price$1.88
Market Cap$193.52M
P/E Ratio-8.3
EV / EBITDA-8.3
Price / Book13.48
Price / Sales6.20
Dividend Yield0.0%
DCF Value (model)$-2.27
DCF Upside vs Price-220.7%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$32.38M
Net Margin-66.8%
Return on Equity-151.0%
Current Ratio1.56
Revenue Growth (YoY)-15.8%
EPS Growth (YoY)-14.3%
Financial Health — source: SEC EDGAR
Altman Z-Score-13.31 (distress)
Valuation vs Sector & Industry
Stock P/E-8.3
Sector P/E (Healthcare)21.0
Industry P/E (Medical Equipment)31.7
vs Sector-139.4%
vs Industry-126.0%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderDAFNA Capital Management LLC ($25.17M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryMedical Equipment
CEODavid Leo Fischel
Employees139
CountryUS
IPO Date2004-08-12

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Orchestra BioMed Holdings, Inc. (OBIO)
  • Quantum-Si incorporated (QSI)
  • Sanara MedTech Inc. (SMTI)
  • Anteris Technologies Global Corp. (AVR)
  • Nyxoah S.A. (NYXH)
  • Nano-X Imaging Ltd. (NNOX)
  • 908 Devices Inc. (MASS)
  • CVRx, Inc. (CVRX)
STXS earnings history · STXS institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.